The most commonly studied biomarkers of sepsis are reviewed for their current uses and diagnostic accuracies, including C-reactive protein, procalcitonin, serum amyloid A, mannan and IFN-γ ...

Next-generation proteomics is enabling researchers to explore the proteome with unprecedented depth and scale. This article ...

The immune system typically can ramp up the body's defenses to clear out an invading threat without issue. Glitches can ...

in sepsis and septic shock patients. Findings published in the paper currently undergoing peer review and accessible on MEDRXIV, demonstrate Nu.Q® NETs H3.1 is a promising novel biomarker for ...

For critically ill patients on antibiotics for suspected sepsis, monitoring one biomarker safely shortened the course of these medications in the ADAPT-Sepsis randomized trial. Daily assessment of ...

The following is a summary of “Study on the diagnostic role of exosome-derived miRNAs in postoperative septic shock and ...

VNRX READ THE FULL VNRX RESEARCH REPORT RECENT EVENTS Nu.Q Discover to be Utilized in a Human Clinical Study On March 4, 2025 ...

The next steps for this work, according to Mithal, include validating newly identified biomarkers to improve timely, accurate diagnosis of early-onset sepsis in newborn infants. The biomarkers ...

At a CV where area under the curve is equal to 1, an ideal biomarker would possess 100% sensitivity, specificity, PPV and NPV. As sepsis can be caused by bacterial, fungal and viral infections ...